Currently predicting for Thu, 4 Jun 2026

LLY Prediction Chart

LLY Predictions History

Latest community submissions for LLY.
Predictor Target Session Target Price Result Direction Accuracy Score
Apr 28, 2023 Bullish $395.86 V 1
Mar 6, 2023 $315.09 -1.05% $318.96 X 98.79% 1
Mar 6, 2023 $320.52 +0.66% $318.96 V 99.51% 5
Mar 6, 2023 Bullish $318.96 V 1
Jan 30, 2023 $346.77 +1.36% $340.50 X 98.16% 0
Jan 30, 2023 $345.02 +0.85% $340.50 X 98.67% 1
Jan 30, 2023 Bearish $340.50 V 1
JS JS Pro
Nov 16, 2022 $347.24 -0.77% $353.02 X 98.36% 0
AlexVel AlexVel Pro
Nov 16, 2022 $353.34 +0.97% $353.02 V 99.91% 10
Nov 16, 2022 $356.98 +2.01% $353.02 V 98.88% 2
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for LLY with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ELI LILLY AND COMPANY
Eli Lilly
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE